What is Mesoblast Ltd?
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.74B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.